Just about to start imho...was no reason for the sell down. Fundamentals still the same and don't forget what STO paid $1 for starters.Good luck to all holders.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%